SKELETAL TUBERCULOSIS IN NEW ZEALAND SINCE THE INTRODUCTION OF CHEMOTHERAPY
| Autor: | V. Johnstone, K. M. Mayo, W. J. Gillespie |
|---|---|
| Rok vydání: | 1987 |
| Předmět: |
Adult
Male medicine.medical_specialty Joint arthroplasty Adolescent medicine.medical_treatment Antitubercular Agents Tuberculosis Osteoarticular medicine Humans Tuberculosis Skeletal tuberculosis Child Aged Chemotherapy Lumbar Vertebrae business.industry General surgery Incidence (epidemiology) Osteoarticular tuberculosis General Medicine Middle Aged Surgery Female Hip Joint Tuberculosis Spinal business New Zealand |
| Zdroj: | ANZ Journal of Surgery. 57:727-732 |
| ISSN: | 1445-2197 1445-1433 |
| DOI: | 10.1111/j.1445-2197.1987.tb01251.x |
| Popis: | The incidence of skeletal tuberculosis in New Zealand as measured by both hospital morbidity and notification data has fallen since the introduction of chemotherapy to low levels comparable with other developed societies. The decline has been greatest in the 5-14 year age group and least in the over 65 group. Individual surgeons can now expect to see few cases in a practising lifetime. Effective chemotherapy is the key to successful treatment. Adequate biopsy is essential, but apart from the drainage of large abscesses the place of surgery in the early management of osteoarticular tuberculosis is discretionary. Early activity can usually be encouraged once chemotherapy is instituted, late reconstruction by joint arthroplasty being available if adequate function is not achieved. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text